DUBLIN, Feb. 15, 2023 /PRNewswire/ -- The "CRISPR Technology Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

The global crispr technology market will grow from $1.33 billion in 2022 to $1.65 billion in 2023 at a compound annual growth rate (CAGR) of 24.6%. The CRISPR technology market is expected to grow to $3.77 billion in 2027 at a CAGR of 22.9%.

North America was the largest region in the CRISPR technology market in 2022. Western Europe was the second largest region in the CRISPR technology market. The regions covered in the CRISPR technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The application of CRISPR technology as a diagnostic tool is expected to boost the market during the period. The Sherlock CRISPR SARS-CoV-2 kit is the first diagnostic kit based on CRISPR technology for infectious diseases caused due to COVID-19. In May 2020, FDA announced the emergency use authorization to the Sherlock BioSciences Inc's Sherlock CRISPR SARS-CoV-2 kit which is a CRISPR-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) diagnostic test.

This test helps in specifically targeting RNA or DNA sequences of the SARS-CoV-2 virus from specimens or samples such as nasal swabs from the upper respiratory tract and fluid in the lungs from bronchoalveolar lavage specimens. This diagnostic kit has high specificity and sensitivity and does not provide false negative or positive results. Widening the application of CRISPR technology for the diagnosis of infectious diseases will increase the demand for CRISPR technology products and services.

Stringent government regulations are expected to limit the growth of the CRISPR technology market during the period. There is no existence of internationally agreed regulatory framework for gene editing products and countries are in the process of evaluating whether and to what extent current regulations are adequate for research conducted with gene editing and applications and products related to gene editing.

The Court of Justice of the European Union ruled that it would treat gene-edited crops as genetically modified organisms, subject to stringent regulation. According to an article of 2020, in India, as per the National Guidelines for Stem Cell Research, genome modification including gene-editing by CRISPR-Cas9 technology of stem cells, germ-line stem cells or gamete and human embryos is restricted only to in-vitro studies. Thus, strict regulations by the government present a threat to the growth of the market.

Several advancements in CRISPR technology are trending in the market during the period. Advancements in technology will help in reducing errors, limiting unintended effects, improving the accuracy of the tool, widening its applications, developing gene therapies and more. In 2020, astudy in Springer Nature stated that researchers have used enzyme engineering to boost the accuracy of the technique of error-prone CRISPR-Cas9 system to precisely target DNA without introducing as many unwanted mutations. The advancements in CRISPR technology will result in better tools that are capable of providing better outcomes.

In March 2021, Integrated DNA Technologies (IDT), a US-based genomics solutions provider, acquired Swift Biosciences. The acquisition aimed at leveraging Swift's academic and clinical research in next-generation sequencing. Swift Biosciences is a US-based company involved in creating genomics kits to prepare Next-Generation Sequencing (NGS) libraries.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.

• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.

• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.

• Measure the impact of high global inflation on market growth.

• Create regional and country strategies on the basis of local data and analysis.

• Identify growth segments for investment.

• Outperform competitors using forecast data and the drivers and trends shaping the market.

• Understand customers based on the latest market shares.

• Benchmark performance against key competitors.

• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Scope
Markets Covered:

1) By Product Type: Design Tools; Plasmid And Vector; Cas9 And G-RNA; Delivery System Products
2) By Application: Genome Editing/Genetic Engineering; Genetically Modified Organisms; Agricultural Biotechnology; Other Applications
3) By End-User: Industrial Biotech; Biological Research; Agricultural Research; Therapeutics And Drug Discovery

Key Topics Covered:

1. Executive Summary

2. CRISPR Technology Market Characteristics

3. CRISPR Technology Market Trends And Strategies

4. CRISPR Technology Market - Macro Economic Scenario

5. CRISPR Technology Market Size And Growth

6. CRISPR Technology Market Segmentation

7. CRISPR Technology Market Regional And Country Analysis

8. Asia-Pacific CRISPR Technology Market

9. China CRISPR Technology Market

10. India CRISPR Technology Market

11. Japan CRISPR Technology Market

12. Australia CRISPR Technology Market

13. Indonesia CRISPR Technology Market

14. South Korea CRISPR Technology Market

15. Western Europe CRISPR Technology Market

16. UK CRISPR Technology Market

17. Germany CRISPR Technology Market

18. France CRISPR Technology Market

19. Eastern Europe CRISPR Technology Market

20. Russia CRISPR Technology Market

21. North America CRISPR Technology Market

22. USA CRISPR Technology Market

23. South America CRISPR Technology Market

24. Brazil CRISPR Technology Market

25. Middle East CRISPR Technology Market

26. Africa CRISPR Technology Market

27. CRISPR Technology Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The CRISPR Technology Market

29. CRISPR Technology Market Future Outlook and Potential Analysis

30. Appendix

A selection of companies mentioned in this report includes

• Thermo Fisher Scientific

• GenScript Biotech Corporation

• CRISPR Therapeutics AG

• Editas Medicine

• Horizon Discovery Plc.

• Integrated DNA Technologies Inc. (Danaher)

• Origene Technologies Inc.

• Transposagenbio Biophramaceuticals (Hera Biolabs)

• Intellia Therapeutics Inc.

• GeneCopoeia Inc.

• Merck KGaA

• Lonza Group Ltd.

• New England Biolabs Inc.

• Sangamo Therapeutics

• Applied StemCell

• Novartis International AG

• Egenesis Inc.

• GE Healthcare Dharmacon Inc.

• Agilent Technologies

• Caribou Biosciences

• Addgene

• Synthego Corporation

• Precision Biosciences

• Cellecta Inc.

For more information about this report visit https://www.researchandmarkets.com/r/4fxmc6-technology?w=5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/crispr-technology-global-market-report-2023-usage-in-diagnostics-set-to-catalyse-growth-301747984.html

SOURCE Research and Markets